Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Gene Therapy-based Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gene Therapy-based Drugmarket, defines the market attractiveness level of Gene Therapy-based Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gene Therapy-based Drug industry, describes the types of Gene Therapy-based Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gene Therapy-based Drug market and the development prospects and opportunities of Gene Therapy-based Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gene Therapy-based Drug market in Chapter 13.
By Player:
Gilead Sciences
AnGes
Orchard Therapeutics
bluebird bio
Novartis
Amgen
SIBIONO
Alnylam Pharmaceuticals
Akcea Therapeutics
Sunway Biotech
Spark Therapeutics
Human Stem Cells Institute
Sarepta Therapeutics
Biogen
By Type:
Viral Gene Delivery System
Non-viral Gene Delivery System
By End-User:
Neurological Diseases
Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gene Therapy-based Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gene Therapy-based Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gene Therapy-based Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gene Therapy-based Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gene Therapy-based Drug Market Analysis and Outlook to 2022
-
7.1 Global Gene Therapy-based Drug Consumption (2017-2022)
-
7.2 United States Gene Therapy-based Drug Consumption (2017-2022)
-
7.3 Europe Gene Therapy-based Drug Consumption (2017-2022)
-
7.4 China Gene Therapy-based Drug Consumption (2017-2022)
-
7.5 Japan Gene Therapy-based Drug Consumption (2017-2022)
-
7.6 India Gene Therapy-based Drug Consumption (2017-2022)
-
7.7 South Korea Gene Therapy-based Drug Consumption (2017-2022)
8 Region and Country-wise Gene Therapy-based Drug Market Analysis and Outlook to 2028
-
8.1 Global Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
8.2 United States Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
8.3 Europe Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
8.4 China Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
8.5 Japan Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
8.6 India Gene Therapy-based Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Gene Therapy-based Drug Consumption Forecast (2022-2028)
9 Global Gene Therapy-based Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Gene Therapy-based Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
9.2 Global Gene Therapy-based Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Gene Therapy-based Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Gene Therapy-based Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gene Therapy-based Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Gene Therapy-based Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gene Therapy-based Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gene Therapy-based Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gene Therapy-based Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gene Therapy-based Drug Market Competitive Analysis
-
14.1 Gilead Sciences
-
14.1.1 Gilead Sciences Company Details
-
14.1.2 Gilead Sciences Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Gilead Sciences Gene Therapy-based Drug Product and Service
-
14.2 AnGes
-
14.2.1 AnGes Company Details
-
14.2.2 AnGes Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AnGes Gene Therapy-based Drug Product and Service
-
14.3 Orchard Therapeutics
-
14.3.1 Orchard Therapeutics Company Details
-
14.3.2 Orchard Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Orchard Therapeutics Gene Therapy-based Drug Product and Service
-
14.4 bluebird bio
-
14.4.1 bluebird bio Company Details
-
14.4.2 bluebird bio Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 bluebird bio Gene Therapy-based Drug Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Gene Therapy-based Drug Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Gene Therapy-based Drug Product and Service
-
14.7 SIBIONO
-
14.7.1 SIBIONO Company Details
-
14.7.2 SIBIONO Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 SIBIONO Gene Therapy-based Drug Product and Service
-
14.8 Alnylam Pharmaceuticals
-
14.8.1 Alnylam Pharmaceuticals Company Details
-
14.8.2 Alnylam Pharmaceuticals Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Alnylam Pharmaceuticals Gene Therapy-based Drug Product and Service
-
14.9 Akcea Therapeutics
-
14.9.1 Akcea Therapeutics Company Details
-
14.9.2 Akcea Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Akcea Therapeutics Gene Therapy-based Drug Product and Service
-
14.10 Sunway Biotech
-
14.10.1 Sunway Biotech Company Details
-
14.10.2 Sunway Biotech Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sunway Biotech Gene Therapy-based Drug Product and Service
-
14.11 Spark Therapeutics
-
14.11.1 Spark Therapeutics Company Details
-
14.11.2 Spark Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Spark Therapeutics Gene Therapy-based Drug Product and Service
-
14.12 Human Stem Cells Institute
-
14.12.1 Human Stem Cells Institute Company Details
-
14.12.2 Human Stem Cells Institute Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Human Stem Cells Institute Gene Therapy-based Drug Product and Service
-
14.13 Sarepta Therapeutics
-
14.13.1 Sarepta Therapeutics Company Details
-
14.13.2 Sarepta Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Sarepta Therapeutics Gene Therapy-based Drug Product and Service
-
14.14 Biogen
-
14.14.1 Biogen Company Details
-
14.14.2 Biogen Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Biogen Gene Therapy-based Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gene Therapy-based Drug
-
Figure Gene Therapy-based Drug Picture
-
Table Global Gene Therapy-based Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy-based Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gene Therapy-based Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gene Therapy-based Drug Consumption by Country (2017-2022)
-
Figure United States Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure China Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure India Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gene Therapy-based Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Gene Therapy-based Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gene Therapy-based Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
Figure Global Non-viral Gene Delivery System Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-viral Gene Delivery System Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gene Therapy-based Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gene Therapy-based Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Gene Therapy-based Drug Product and Service
-
Table AnGes (Foundation Year, Company Profile and etc.)
-
Table AnGes Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AnGes Gene Therapy-based Drug Product and Service
-
Table Orchard Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Orchard Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orchard Therapeutics Gene Therapy-based Drug Product and Service
-
Table bluebird bio (Foundation Year, Company Profile and etc.)
-
Table bluebird bio Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table bluebird bio Gene Therapy-based Drug Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Gene Therapy-based Drug Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Gene Therapy-based Drug Product and Service
-
Table SIBIONO (Foundation Year, Company Profile and etc.)
-
Table SIBIONO Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table SIBIONO Gene Therapy-based Drug Product and Service
-
Table Alnylam Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Alnylam Pharmaceuticals Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alnylam Pharmaceuticals Gene Therapy-based Drug Product and Service
-
Table Akcea Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Akcea Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akcea Therapeutics Gene Therapy-based Drug Product and Service
-
Table Sunway Biotech (Foundation Year, Company Profile and etc.)
-
Table Sunway Biotech Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sunway Biotech Gene Therapy-based Drug Product and Service
-
Table Spark Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Spark Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spark Therapeutics Gene Therapy-based Drug Product and Service
-
Table Human Stem Cells Institute (Foundation Year, Company Profile and etc.)
-
Table Human Stem Cells Institute Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Human Stem Cells Institute Gene Therapy-based Drug Product and Service
-
Table Sarepta Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Sarepta Therapeutics Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sarepta Therapeutics Gene Therapy-based Drug Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Gene Therapy-based Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Gene Therapy-based Drug Product and Service
-
